Delivery Order SPE2DB22D3501-SPE2DB25FVW43
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,213.74 to AmerisourceBergen Drug Corp for Scopolamine 1 mg/3 Day Patch in a quantity of 24 units. This contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 day patches (24-count units) under a firm fixed price contract valued at $4,490.44. The order, with an ultimate completion date of September 18, 2025, was competitively awarded without set-aside designations. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Scopolamine 1 mg/3 day patches (24-count) with a contract ceiling value of $1,662.03. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and...
- The Defense Logistics Agency awarded a $6,048.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Scopolamine 1 mg/3 day patches in quantities of 24 units. The delivery order, which represents a competitively awarded non-set-aside contract, is scheduled for ultimate completion on July 24, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 day patches (24-count units) under a firm fixed-price contract with a ceiling value of $1,830.00. The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,759.39 to AmerisourceBergen Drug Corp for Scopolamine 1 mg/3 Day Patch in a quantity of 24 units. This firm fixed-price, competitively awarded contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,206,735 units of the medication Scopolamine 1 mg/3 day patch. The contract is valued at $1,198.43 with an ultimate completion date of April 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Scopolamine 1 mg/3 day patches (24-count) valued at $1,765.94. The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,211.27 delivery order on September 16, 2025, for Scopolamine 1 mg/3 day patches (24-count units), with an ultimate completion date of September 17, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents product delivery to support federal healthcare needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,235.46 to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 day patches (24-unit quantity) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVW43Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,640.23 to AmerisourceBergen Drug Corp for the supply of Scopolamine 1 mg/3 Day Patch in quantities of 24 units. The contract carries a firm fixed price structure with no set-aside designation, indicating open competitive procurement. The award was finalized on May 30, 2025, with an ultimate completion date of June 2, 2025. Performance of this delivery order will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The primary IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply medications, medical supplies, and related healthcare commodities to military and federal healthcare systems globally. Scopolamine patches are commonly used for motion sickness prevention and other therapeutic applications within military medical operations, making this a routine pharmaceutical supply order consistent with the broader IDC's scope of providing diverse therapeutic medications to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/30/25 |